Green light for £30m Sir Bobby Robson Institute in Newcastle

Plans to build a £30m cancer research centre in Newcastle - to be called The Sir Bobby Robson Institute – have been given the green light, meaning construction can commence in early 2026.

The three-storey facility will be located next to the existing Northern Centre for Cancer Care at Freeman Hospital in the city.

Work is set to commence in 2026placeholder image
Work is set to commence in 2026 | The Sir Bobby Robson Foundation

It will bring together the current Sir Bobby Robson Cancer Trials Research Centre and the hospital's cancer and blood disorders (oncology and haematology) research team.

Work is set to commence in 2026placeholder image
Work is set to commence in 2026 | The Sir Bobby Robson Foundation

Once operational, the building will provide additional capacity to increase the number of cancer clinical trials taking place in Newcastle, allowing a 50 per cent increase in activity over five years.

While the institute's catchment area will cover around 3.5million people living in the north east, north Cumbria and north Yorkshire, the work carried out there could benefit people around the globe.

Construction is being funded by The Sir Bobby Robson Foundation, part of Newcastle Hospitals Charity. With £20m raised so far by supporters, a fundraising campaign is now ramping up to raise the final £10m.

Professor Ruth Plummer, consultant medical oncologist at Newcastle Hospitals and director of the Sir Bobby Robson Cancer Trials Research Centre, said: "Demand for more research into new and innovative cancer treatments is rising, globally and locally.

"At Newcastle Hospitals we have skilled and experienced teams who are already carrying out ground-breaking cancer clinical trials.

"Over the years, we have become increasingly busy and current limitations mean our space to conduct more trials is restricted so, frustratingly, the team cannot accept some research programmes or requests.

"I'm absolutely thrilled that we've been given permission to build this new facility, which will allow us to provide timely access to clinical trials for many more eligible cancer patients, including those who have exhausted current treatments."

Teri Bayliss, director at Newcastle Hospitals Charity, added: "This project will be the proud culmination of a phenomenal fundraising effort and, alongside the many cancer patients who will benefit from the scientific advances made by the trials team, we are extremely grateful to all those who are supporting the project.

"We are particularly indebted to those organisations and individuals who have shown leadership support for our fundraising campaign, including the Sir James Knott Trust, NorthStandard and Esh Group."

Construction on the institute will begin early 2026, with opening planned for 2028.

Follow us
© 2026 Iconic Media Group Ltd. All rights reserved.Cookie SettingsTerms and ConditionsPrivacy notice